Pifithrin-β hydrobromide NEW
| Price | $34 | $51 | $85 |
| Package | 2mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2026-04-21 |
Product Details
| Product Name: Pifithrin-β hydrobromide | CAS No.: 511296-88-1 |
| Purity: 99.74% | Supply Ability: 10g |
| Release date: 2026/04/21 |
Product Introduction
Bioactivity
| Name | Pifithrin-β hydrobromide |
| Description | Pifithrin-β hydrobromide (Cyclic PFT-α) is an inhibitor of p53; reversibly blocks p53-dependent transcriptional activation and apoptosis. Protects against neuronal death in models of stroke and neurodegenerative disorders. Active in vivo; protects mice from the side-effects of Y therapy associated with p53 induction. Supresses self-renewal of embryonic stem cells. Also aryl hydrocarbon receptor (AHR) agonist, causes upregulation of AHR target gene CYP1A1 (EC50 = 1.1 μM). |
| In vitro | PFTα molecule could not take a planar conformation required for AhR activation whereas Pifithrin-β hydrobromide showed a conformation similar to those of the prototypical AhR ligand β-naphthoflavone. In both cell lines, PFTα and Pifithrin-β hydrobromide provoked different responses related with AhR activation. However, when cyclization of PFTα to Pifithrin-β hydrobromide was hampered by acetylation of the exocyclic nitrogen, all these responses were not observed. These results lead to the conclusion that the activation of the AhR is probably caused by Pifithrin-β hydrobromide instead of PFTα. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 13.89 mg/mL (39.77 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (2.86 mM), Sonication is recommended. |
| Keywords | Pifithrin-β Hydrobromide | Pifithrinβ hydrobromide | Pifithrin-beta Hydrobromide | Pifithrin-beta | Pifithrin-b Hydrobromide | Pifithrin-b | Pifithrin β hydrobromide | PFT-beta | PFT-b | PFT β | PFT beta | PFT b | p53 | MDM-2/p53 | Ferroptosis | Cyclic Pifithrin-α | Cyclic Pifithrin-alpha Hydrobromide | Cyclic Pifithrin-a Hydrobromide | Cyclic PFT-alpha | Cyclic PFT-a |
| Inhibitors Related | Flubendazole | Rosiglitazone | Hemin | L-Glutamic acid | Sorafenib | Curcumin | L-Cystine | L-Glutamine | (-)-Epigallocatechin Gallate | Coenzyme Q10 | Baicalein | Sodium Molybdate |
| Related Compound Libraries | Ferroptosis Compound Library | Anti-Lung Cancer Compound Library | Glycometabolism Compound Library | Bioactive Compound Library | Ubiquitination Compound Library | Inhibitor Library | Stem Cell Differentiation Compound Library | PPI Inhibitor Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Transcription Factor-Targeted Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2590.00/50mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-21 | |
| $2.00/100kg |
VIP1Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2025-08-22 | |
| $10.00/25kg |
VIP4Y
|
Enki Biopharmaceuticals (Shanghai) Limited
|
2023-11-01 | |
| $1.00/1g |
VIP7Y
|
Career Henan Chemical Co
|
2019-12-20 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY